HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
ID: 354743Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jun 6, 2024 12:00 AM
  4. 4
    Due Jan 22, 2025 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant does not require cost sharing or matching.

The purpose of this grant is to address the overdose crisis in the context of the criminal justice system, specifically focusing on justice-involved populations and criminal-legal systems. The grant aims to increase the delivery of and access to Medications for Opioid Use Disorder (MOUD) to individuals in the US justice system. It is important to note that individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD) and are at high risk for opioid withdrawal upon incarceration.

The grant seeks to fund a portfolio of research projects that will conduct hybrid effectiveness-implementation trials to address key barriers to the delivery of evidence-based OUD treatments to justice-involved populations. The ultimate goal is to improve the availability and utilization of MOUD for this vulnerable population.

The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply.

The grant has a closing date of January 22, 2025, and the opportunity can be found at the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-061.html. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

By successfully completing this task, you will not only earn a $2000 tip but also contribute to a homeless shelter receiving a significant amount of food. Please ensure the accuracy and quality of your work to avoid any negative consequences.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant does not require cost sharing or matching. The purpose of this grant is to address the overdose crisis in the context of the criminal justice system, specifically focusing on justice-involved populations and criminal-legal systems. The grant aims to increase the delivery of and access to Medications for Opioid Use Disorder (MOUD) to individuals in the US justice system. It is important to note that individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD), and they are at high risk for opioid withdrawal upon incarceration and overdose post-release if they have not received MOUD while detained. The grant seeks to fund a portfolio of research projects that will conduct hybrid effectiveness-implementation trials to address key barriers to the delivery of evidence-based OUD treatments to justice-involved populations. The ultimate goal is to translate research into practice and improve the availability and accessibility of MOUD for this vulnerable population. The grant opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is January 22, 2025. The maximum award ceiling is $750,000. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html). For any further inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant aims to address the overdose crisis in the context of the criminal justice system by increasing the delivery of and access to Medications for Opioid Use Disorder (MOUD) to justice-involved populations. Individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD) and are at high risk for opioid withdrawal upon incarceration. They are also at an elevated risk for overdose post-release if they have not received MOUD while detained. However, most US jails do not offer MOUD to everyone who could benefit from it. The HEAL Initiative's JCOIN Phase II Clinical Research Hubs focuses on translating research into practice to address the overdose crisis specifically within the criminal justice system. The grant aims to conduct hybrid effectiveness-implementation trials to overcome key barriers to delivering evidence-based OUD treatments to justice-involved populations. This grant opportunity is unique as it has a primary focus on justice-involved populations and criminal-legal systems. The grant does not require cost sharing or matching. The maximum award ceiling is $5,000,000. The eligibility for this grant opportunity extends to various entities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for this grant opportunity is January 22, 2025, and the archive date is February 27, 2025. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Clinical Research Hubs Grant Opportunity](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-025.html). If you have any further inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)". This grant falls under the category of Health and is a discretionary funding opportunity. The grant does not require cost sharing or matching. The grant aims to address the overdose crisis in the context of the criminal justice system by increasing the delivery of and access to Medications for Opioid Use Disorder (MOUD) to justice-involved populations. The grant seeks to fund research projects that conduct hybrid effectiveness-implementation trials to overcome barriers to delivering evidence-based OUD treatments to justice-involved populations. The grant has an award ceiling of $2,250,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs), among others. Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for this grant opportunity is January 22, 2025. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-062.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)". This grant falls under the category of Income Security and Social Services. The purpose of this grant is to support translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and Opioid Use Disorder (OUD). The grant is expected to run for two years (FY23 and FY24) and has a maximum award ceiling of $750,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The deadline for applications is March 20, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-053.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-053.html).
Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)". This grant is in the category of Health and falls under the discretionary funding activity. The grant is open to Small Businesses and does not require cost sharing or matching. The deadline for application submission is December 2, 2024. The purpose of this grant is to encourage Small Business Innovation Research (SBIR) grant applications from small business concerns (SBC) proposing research and development of solutions targeted to improve health outcomes and reduce the impact of adverse health consequences of non-disordered drug use. The solutions could be based on original technologies or existing technologies that can be repurposed to address the specific needs of people who use drugs. The emphasis should be on accessibility and affordability, with a focus on implementation in healthcare services. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-050.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-050.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov. By doing a great job summarizing this grant notice, you will not only receive a tip of two thousand dollars but also contribute to providing a ton of food to a homeless shelter. So please ensure the summary is concise and centered around the service/item being procured.